The necessity of implantable cardioverter defibrillators in patients with Kearns-Sayre syndrome - systematic review of the articles -

Tomohiko Imamura, Naokata Sumitomo, Shota Muraji, Hitoshi Mori, Yousuke Osada, Takayuki Oyanagi, Takuro Kojima, Shigeki Yoshiba, Toshiki Kobayashi, Katsushige Ono

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The most common cardiac feature of Kearns-Sayre syndrome (KSS) is atrioventricular block (AVB), and pacemaker implantations (PMIs) are recommended for KSS patients with advanced AVB. However, some KSS patients develop fatal arrhythmias such as polymorphic ventricular tachycardia (PMVT) and ventricular fibrillation (VF) and die suddenly even after PMIs. We report a patient with KSS who developed PMVT, VF, and QT prolongation, and was treated with mexiletine and successfully managed with an implantable cardioverter defibrillator (ICD). We reviewed the literature on arrhythmias in KSS published from 1975 to 2018. There were 112 patients with arrhythmia-associated KSS, 10 died, and 6 died suddenly after the PMI. The first manifestation of an arrhythmia was bundle branch block, then it progressed to AVB, and developed into complete AVB (CAVB) in about half the KSS patients. Ventricular arrhythmias were documented in 12 patients, and 8 were implanted with defibrillators afterwards. One patient after the implantation of a cardiac resynchronization therapy defibrillator (CRT-D) was treated for VF by an appropriate shock. This fact suggested that VF occurred even under proper pacing, and that defibrillators were effective. Pacemakers may suppress early afterdepolarizations (EADs) associated with a QT prolongation due to bradycardia. Similarly, mexiletine may suppress EADs by blocking the late sodium and Ca currents. Ventricular arrhythmias observed under suppression of EADs may be caused by delayed afterdepolarization (DADs) via an increasing intracellular Ca concentration due to mitochondrial dysfunction. Therefore, a PMI alone may not be sufficient to prevent sudden death, and an ICD implantation should be necessary.

Original languageEnglish
Pages (from-to)105-111
Number of pages7
JournalInternational Journal of Cardiology
Volume279
DOIs
Publication statusPublished - 2019 Mar 15
Externally publishedYes

Fingerprint

Kearns-Sayre Syndrome
Implantable Defibrillators
Cardiac Arrhythmias
Atrioventricular Block
Ventricular Fibrillation
Defibrillators
Mexiletine
Ventricular Tachycardia
Cardiac Resynchronization Therapy
Bundle-Branch Block
Bradycardia
Sudden Death
Shock
Sodium

Keywords

  • Atrioventricular block
  • Implantable cardioverter defibrillator
  • Kearns-Sayre syndrome
  • Long QT
  • Ventricular fibrillation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The necessity of implantable cardioverter defibrillators in patients with Kearns-Sayre syndrome - systematic review of the articles -. / Imamura, Tomohiko; Sumitomo, Naokata; Muraji, Shota; Mori, Hitoshi; Osada, Yousuke; Oyanagi, Takayuki; Kojima, Takuro; Yoshiba, Shigeki; Kobayashi, Toshiki; Ono, Katsushige.

In: International Journal of Cardiology, Vol. 279, 15.03.2019, p. 105-111.

Research output: Contribution to journalArticle

Imamura, Tomohiko ; Sumitomo, Naokata ; Muraji, Shota ; Mori, Hitoshi ; Osada, Yousuke ; Oyanagi, Takayuki ; Kojima, Takuro ; Yoshiba, Shigeki ; Kobayashi, Toshiki ; Ono, Katsushige. / The necessity of implantable cardioverter defibrillators in patients with Kearns-Sayre syndrome - systematic review of the articles -. In: International Journal of Cardiology. 2019 ; Vol. 279. pp. 105-111.
@article{c5910f276dcb44c2994397dcc7ac38a5,
title = "The necessity of implantable cardioverter defibrillators in patients with Kearns-Sayre syndrome - systematic review of the articles -",
abstract = "The most common cardiac feature of Kearns-Sayre syndrome (KSS) is atrioventricular block (AVB), and pacemaker implantations (PMIs) are recommended for KSS patients with advanced AVB. However, some KSS patients develop fatal arrhythmias such as polymorphic ventricular tachycardia (PMVT) and ventricular fibrillation (VF) and die suddenly even after PMIs. We report a patient with KSS who developed PMVT, VF, and QT prolongation, and was treated with mexiletine and successfully managed with an implantable cardioverter defibrillator (ICD). We reviewed the literature on arrhythmias in KSS published from 1975 to 2018. There were 112 patients with arrhythmia-associated KSS, 10 died, and 6 died suddenly after the PMI. The first manifestation of an arrhythmia was bundle branch block, then it progressed to AVB, and developed into complete AVB (CAVB) in about half the KSS patients. Ventricular arrhythmias were documented in 12 patients, and 8 were implanted with defibrillators afterwards. One patient after the implantation of a cardiac resynchronization therapy defibrillator (CRT-D) was treated for VF by an appropriate shock. This fact suggested that VF occurred even under proper pacing, and that defibrillators were effective. Pacemakers may suppress early afterdepolarizations (EADs) associated with a QT prolongation due to bradycardia. Similarly, mexiletine may suppress EADs by blocking the late sodium and Ca currents. Ventricular arrhythmias observed under suppression of EADs may be caused by delayed afterdepolarization (DADs) via an increasing intracellular Ca concentration due to mitochondrial dysfunction. Therefore, a PMI alone may not be sufficient to prevent sudden death, and an ICD implantation should be necessary.",
keywords = "Atrioventricular block, Implantable cardioverter defibrillator, Kearns-Sayre syndrome, Long QT, Ventricular fibrillation",
author = "Tomohiko Imamura and Naokata Sumitomo and Shota Muraji and Hitoshi Mori and Yousuke Osada and Takayuki Oyanagi and Takuro Kojima and Shigeki Yoshiba and Toshiki Kobayashi and Katsushige Ono",
year = "2019",
month = "3",
day = "15",
doi = "10.1016/j.ijcard.2018.12.064",
language = "English",
volume = "279",
pages = "105--111",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - The necessity of implantable cardioverter defibrillators in patients with Kearns-Sayre syndrome - systematic review of the articles -

AU - Imamura, Tomohiko

AU - Sumitomo, Naokata

AU - Muraji, Shota

AU - Mori, Hitoshi

AU - Osada, Yousuke

AU - Oyanagi, Takayuki

AU - Kojima, Takuro

AU - Yoshiba, Shigeki

AU - Kobayashi, Toshiki

AU - Ono, Katsushige

PY - 2019/3/15

Y1 - 2019/3/15

N2 - The most common cardiac feature of Kearns-Sayre syndrome (KSS) is atrioventricular block (AVB), and pacemaker implantations (PMIs) are recommended for KSS patients with advanced AVB. However, some KSS patients develop fatal arrhythmias such as polymorphic ventricular tachycardia (PMVT) and ventricular fibrillation (VF) and die suddenly even after PMIs. We report a patient with KSS who developed PMVT, VF, and QT prolongation, and was treated with mexiletine and successfully managed with an implantable cardioverter defibrillator (ICD). We reviewed the literature on arrhythmias in KSS published from 1975 to 2018. There were 112 patients with arrhythmia-associated KSS, 10 died, and 6 died suddenly after the PMI. The first manifestation of an arrhythmia was bundle branch block, then it progressed to AVB, and developed into complete AVB (CAVB) in about half the KSS patients. Ventricular arrhythmias were documented in 12 patients, and 8 were implanted with defibrillators afterwards. One patient after the implantation of a cardiac resynchronization therapy defibrillator (CRT-D) was treated for VF by an appropriate shock. This fact suggested that VF occurred even under proper pacing, and that defibrillators were effective. Pacemakers may suppress early afterdepolarizations (EADs) associated with a QT prolongation due to bradycardia. Similarly, mexiletine may suppress EADs by blocking the late sodium and Ca currents. Ventricular arrhythmias observed under suppression of EADs may be caused by delayed afterdepolarization (DADs) via an increasing intracellular Ca concentration due to mitochondrial dysfunction. Therefore, a PMI alone may not be sufficient to prevent sudden death, and an ICD implantation should be necessary.

AB - The most common cardiac feature of Kearns-Sayre syndrome (KSS) is atrioventricular block (AVB), and pacemaker implantations (PMIs) are recommended for KSS patients with advanced AVB. However, some KSS patients develop fatal arrhythmias such as polymorphic ventricular tachycardia (PMVT) and ventricular fibrillation (VF) and die suddenly even after PMIs. We report a patient with KSS who developed PMVT, VF, and QT prolongation, and was treated with mexiletine and successfully managed with an implantable cardioverter defibrillator (ICD). We reviewed the literature on arrhythmias in KSS published from 1975 to 2018. There were 112 patients with arrhythmia-associated KSS, 10 died, and 6 died suddenly after the PMI. The first manifestation of an arrhythmia was bundle branch block, then it progressed to AVB, and developed into complete AVB (CAVB) in about half the KSS patients. Ventricular arrhythmias were documented in 12 patients, and 8 were implanted with defibrillators afterwards. One patient after the implantation of a cardiac resynchronization therapy defibrillator (CRT-D) was treated for VF by an appropriate shock. This fact suggested that VF occurred even under proper pacing, and that defibrillators were effective. Pacemakers may suppress early afterdepolarizations (EADs) associated with a QT prolongation due to bradycardia. Similarly, mexiletine may suppress EADs by blocking the late sodium and Ca currents. Ventricular arrhythmias observed under suppression of EADs may be caused by delayed afterdepolarization (DADs) via an increasing intracellular Ca concentration due to mitochondrial dysfunction. Therefore, a PMI alone may not be sufficient to prevent sudden death, and an ICD implantation should be necessary.

KW - Atrioventricular block

KW - Implantable cardioverter defibrillator

KW - Kearns-Sayre syndrome

KW - Long QT

KW - Ventricular fibrillation

UR - http://www.scopus.com/inward/record.url?scp=85059817513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059817513&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2018.12.064

DO - 10.1016/j.ijcard.2018.12.064

M3 - Article

C2 - 30642644

AN - SCOPUS:85059817513

VL - 279

SP - 105

EP - 111

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

ER -